Aurora Cannabis Inc. ACB 深 滬
交易中 06-25 10:16:38 美东时间
2.79
-0.040
-1.41%
華盛通- 最 高2.86
- 今 開2.85
- 成交量 13.75万股
- 最 低 2.79
- 昨 收 2.83
- 總市值 1.73亿
- 52周最高 6.665
- 市盈率 靜 --
- 換手率 0.22%
- 52周最低 2.73
- 委 比 46.84%
- 總股本 6194.21万
- 歷史最高 1238.40
- 量 比 1.26
- 振 幅 2.47%
- 歷史最低 2.73
- 每 手 1
- 風險率 0.76%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多CRON拓展全球布局 这支大麻类股票是否值得买入
核心事件：大麻企业Cronos集团（股票代码CRON）披露2026年第一季度业绩，同时其行业竞争环境、股价表现及评级情况被梳理，为投资者提供操作参考。 关键数据...
06-24 21:35
电话会总结 ｜ Aurora(ACB)2026财年Q4业绩电话会核心要点
<span style="color:#999999;">编者按：聚焦公司高管观点与展望，深挖业绩背后的信息，助力投资者把握先机。</span><blockquote><p><span style="color:#fa1432;"><strong>业绩回顾</strong></span></p></blockquote><p>• 根据Aurora Cannabis业绩会实录，以下是财务业绩回顾摘要： ## 1. 财务业绩 **年度业绩（2026财年）：** - 净营收：3.21亿加元，同比增长11%，其中55%来自加拿大以外市场 - 调整后毛利率：64%（年度） - 调整后EBITDA：5,400万加元，同比增长32% - 现金及等价物：1.65亿加元，无债务 - 自由现金流：30万加元，同比减少490万加元 **季度业绩（2026财年第四季度）：** - 净营收：8,480万加元，同比增长10% - 医用大麻净营收：7,710万加元，同比增长14%，占总营收的91% - 国
06-12 12:10
Aurora Cannabis Signals Strong 2026, Transitional 2027
Aurora Cannabis (US) (($TSE:ACB)) has held its Q4 earnings call. Read on for th...
06-12 08:05
Aurora Cannabis公布2026财年业绩：营收与调整后EBITDA双双创纪录
加拿大医用大麻公司Aurora Cannabis周四公布截至2026年3月31日的第四财季及全年财报。数据显示，公司全年全球医用大麻净营收达2.886亿美元...
06-11 23:05
Aurora Cannabis dips after projecting a revenue decline for FY27
Aurora Cannabis (ACB) traded lower in the premarket on Thursday after the Canadian cannabis company, with its Q4 FY26 results, provided an underwhelming outlook, indicating a revenue decline for fisca...
06-11 20:15
Aurora Cannabis Q4 EPS $(0.35) Misses $(0.07) Estimate, Sales $61.842M Beat $55.290M Estimate
Aurora Cannabis (NASDAQ:ACB) reported quarterly losses of $(0.35) per share which missed the analyst consensus estimate of $(0.07) by 400 percent. This is a 45.83 percent decrease over losses of $(0.24) per share from the same period last year. The company reported quarterly sales of $61.842 million...
06-11 19:16
Aurora Cannabis Q4 EPS $(0.48) Misses $(0.14) Estimate, Sales $84.816M Beat $75.200M Estimate
Aurora Cannabis (TSX:ACB) reported quarterly losses of $(0.48) per share which missed the analyst consensus estimate of $(0.14) by 242.86 percent. This is a 37.14 percent decrease over losses of $(0.35) per share from the same period last year. The company reported quarterly sales of $84.816 million...
06-11 19:15
Aurora Cannabis publishes MD&A for fiscal 2026 and 2025 years ended March 31
Aurora Cannabis publishes MD&A for fiscal 2026 and 2025 years ended March 31 Aurora Cannabis published its fiscal 2026 MD&A, highlighting a strategic pivot toward global medical cannabis while winding down most Canadian consumer activity. Fiscal 2027 outlook calls for total net revenue to decline to
06-11 19:12
Earnings Scheduled For June 11, 2026
Companies Reporting Before The Bell • Global X Guru Index ETF (NYSE:GURU) is expected to report quarterly loss at $0.02 per share on revenue of $9.01 million. • Lovesac (NASDAQ:LOVE) is likely to report quarterly loss at $0.93 per share on revenue of $136.49 million. • WisdomTree True Developed Inte...
06-11 19:11
Aurora Cannabis reports Q4 results
Aurora Cannabis press release (ACB): Q4 Adjusted net income was C$5.6 million Revenue of C$84.82M (+10.5% Y/Y) beats by C$9.4M. More on Aurora Cannabis Inc. Aurora Cannabis: Why I Like This Stock Wall...
06-11 19:07
